xIPOmeter
Owkin
Owkin provides a platform for life sciences companies, researchers, and hospitals that enables them to exchange medical information while retaining the privacy of patients. The platform also allows to simplify the process of drug discovery by providing AI insights from large datasets.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
News related to Owkin36
OwkinOwkin and Proscia Expand Access to AI Pre-Screening for ...
PARIS & PHILADELPHIA, November 19, 2024--Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, ...
https://finance.yahoo.com/news/owkin-proscia-expand-access-ai-131500556.htmlOwkinOwkin Announces MSIntuit® CRC v2, a Next-Generation AI ...
Owkin Announces MSIntuit® CRC v2, a Next-Generation AI Diagnostic Aimed at Transforming the Detection and Treatment of Colorectal Cancer....
https://www.morningstar.com/news/business-wire/20241029137143/owkin-announces-msintuit-crc-v2-a-next-generation-ai-diagnostic-aimed-at-transforming-the-detection-and-treatment-of-colorectal-cancerOwkinOwkin Announces MSIntuit® CRC v2, a Next-Generation AI ...
PARIS, October 29, 2024--Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, ...
https://finance.yahoo.com/news/owkin-announces-msintuit-crc-v2-080000461.htmlOwkinOwkin and AstraZeneca to develop AI tool for breast cancer testing
Owkin has announced a partnership with AstraZeneca to create an AI gBRCA pre-screening solution designed to identify mutations in breast cancer patients ...
https://finance.yahoo.com/news/owkin-astrazeneca-develop-ai-tool-105257775.htmlOwkinOwkin Announces Partnership with AstraZeneca to Develop an AI ...
Owkin and AstraZeneca have announced a partnership to develop an AI-powered tool to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from ...
https://finance.yahoo.com/news/owkin-announces-partnership-astrazeneca-develop-070000613.html
Show more (31)